Acceleration, Incubation & Venture building service
MedTech Revenue Readiness: Strategic Reimbursement & Commercial Access
Provided by Munich MedTech (a brand of AR2-C2 GmbH) · Germany
Service description
Service Overview: This service bridges the critical gap between regulatory clearance and commercial viability. While your regulatory strategy grants the "license to sell," this service secures the "license to get paid." We provide a comprehensive Market Access & Reimbursement Strategy designed to satisfy hospital procurement committees, public/private payers, and venture capital due diligence requirements. Key Deliverables & Methodology: Our approach begins with a rigorous Reimbursement Landscape Analysis, identifying applicable CPT/DRG codes and payment pathways across your target markets (e.g., US CMS, EU5).1 We move beyond simple coding to execute Health Economics & Outcomes Research (HEOR), constructing budget impact models that translate your clinical data into a quantifiable economic value proposition.